what is the equivalent dose of tirzepatide to semaglutide and Dosage Charts: A Complete Guide Semaglutide to Tirzepatide: When to

Cardiovascular risk: Clinical data reported a 20% reduction in major adverse cardiovascular events

Research shows that semaglutide users experience an average LDL reduction of 510% and triglyceride improvements, making it a dual-action therapy for metabolic health

Medications vary by patient

According to the MHRA/EMC SmPC, these include: Vomiting reported in approximately 8% of patients Abdominal pain and discomfort cramping or bloating may make it difficult to find a comfortable sleeping position Acid reflux or heartburn which can worsen when lying down Hypoglycaemia (low blood glucose) may occur, particularly when Ozempic is used in combination with sulphonylureas or insulin